IP Library Granted Patent US 10,081,697
Granted Patent B2
US 10,081,697 · App. 15/376,700 · Granted Sep 25, 2018

Hydrophilized polydiorganosiloxane vinylic crosslinkers and uses thereof

Inventors: Jinyu Huang (Ridgewood, NJ); Frank Chang (Cumming, GA); Steve Yun Zhang (Sugar Hill, GA); Feng Jing (Snellville, GA)
Assignee: Novartis AG
C08F290/068C08G77/16C08G77/20C08G77/392G02B1/043C08G77/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,081,697
App. No.
15/376,700
Granted
Sep 25, 2018
Kind
B2
Abstract

The invention provides a hydrophilized polydiorganosiloxane vinylic crosslinker which comprises (1) a polydiorganosiloxane polymer chain comprising dimethylsiloxane units and hydrophilized siloxane units each having one methyl substituent and one monovalent C 4 -C 40 organic radical substituent having two to six hydroxyl groups, wherein the molar ratio of the hydrophilized siloxane units to the dimethylsiloxane units is from about 0.035 to about 0.15, and (2) two terminal (meth)acryloyl groups. The hydrophilized polydiorganosiloxane vinylic crosslinker has a number average molecular weight of from about 3000 Daltons to about 80,000 Daltons. The present invention is also related to a silicone hydrogel contact lens, which comprises repeating units derived from a hydrophilized polydiorganosiloxane vinylic crosslinker of the invention.

Claims (47)

1. A polydiorganosiloxane vinylic crosslinker, comprising: (1) a polydiorganosiloxane polymer chain comprising dimethylsiloxane units and siloxane unit having one methyl substituent and one monovalent C 4 -C 40 organic radical substituent having two to six hydroxyl groups, wherein the molar ratio of the hydrophilized siloxane units to the dimethylsiloxane units is from about 0.035 to about 0.15; (2) two terminal (meth)acryloyl groups, wherein the polydiorganosiloxane vinylic crosslinker has a number average molecular weight of from about 3000 Daltons to about 80,000 Daltons.

2. The polydiorganosiloxane vinylic crosslinker of claim 1 , wherein the polydiorganosiloxane vinylic crosslinker is a polymer of formula (1)

in which:

υ1 is an integer of from 30 to 500 and ω1 is an integer of from 1 to 75, provided that ω1/υ1 is from about 0.035 to about 0.15;

X 0 is O or NR′ in which R′ is hydrogen or C 1 -C 10 -alkyl;

R 1 is hydrogen or methyl;

R 2 and R 3 independently of each other are a substituted or unsubstituted C 1 -C 10 alkylene divalent radical or a divalent radical of —R 5 —O—R 6 — in which R 5 and R 6 independently of each other are a substituted or unsubstituted C 1 -C 10 alkylene divalent radical;

R 4 is a monovalent radical of any one of formula (2) to (6)

q1 is zero or 1;

n1 is an integer of 2 to 4;

n2 is an integer of 1 to 5;

n3 is an integer of 3 to 6;

n4 is an integer of 2 to 5

R 7 is hydrogen or methyl;

R 8 and R 9 independent of each other are a C 2 -C 6 hydrocarbon radical having (n2+1) valencies;

R 10 is ethyl or hydroxymethyl;

R 11 is methyl or hydromethyl;

R 12 is hydroxyl or methoxy;

X 1 is a sulfur linkage of —S— or a tertiary amino linkage of —NR 13 — in which R 13 is C 1 -C 3 alkyl, hydroxylethyl, hydroxypropyl, or 2,3-dihydroxypropyl; and

X 2 is an amide linkage of

in which R 14 is hydrogen or C 1 -C 10 alkyl.

3. The polydiorganosiloxane vinylic crosslinker of claim 2 , wherein R 4 is a monovalent radical of formula (2).

4. The polydiorganosiloxane vinylic crosslinker of claim 3 , wherein R 4 is a monovalent radical of any one of formula (2a) to (2y)

in which q1 is zero or 1, n1 is an integer of 2 to 4, R 7 is hydrogen or methyl.

5. The polydiorganosiloxane vinylic crosslinker of claim 2 , wherein R 4 is a monovalent radical of formula (3).

6. The polydiorganosiloxane vinylic crosslinker of claim 5 , wherein R 4 is a monovalent radical of any one of formula (3a) to (3y)

in which X 2 is an amide linkage of

in which R 14 is hydrogen or C 1 -C 10 alkyl.

7. The polydiorganosiloxane vinylic crosslinker of claim 2 , wherein R 4 is a monovalent radical of formula (4).

8. The polydiorganosiloxane vinylic crosslinker of claim 7 , wherein R 4 is a monovalent radical of formula (4a) or (4b)

9. The polydiorganosiloxane vinylic crosslinker of claim 2 , wherein R 4 is a monovalent radical of formula (5).

10. The polydiorganosiloxane vinylic crosslinker of claim 9 , wherein R 4 is a monovalent radical of any one of formula (5a) to (5c)

11. The polydiorganosiloxane vinylic crosslinker of claim 2 , wherein R 4 is a monovalent radical of formula (6).

12. The polydiorganosiloxane vinylic crosslinker of claim 11 , wherein in formula (6) n1 is 3 and q1 is 1.

13. The polydiorganosiloxane vinylic crosslinker of claim 3 , wherein in formula (1) X 0 is O.

14. The polydiorganosiloxane vinylic crosslinker of claim 3 , wherein in formula (1) X 0 is NR′ in which R′ is hydrogen or C 1 -C 10 -alkyl.

15. The polydiorganosiloxane vinylic crosslinker of claim 5 , wherein in formula (1) X 0 is O.

16. The polydiorganosiloxane vinylic crosslinker of claim 5 , wherein in formula (1) X 0 is NR′ in which R′ is hydrogen or C 1 -C 10 -alkyl.

17. The polydiorganosiloxane vinylic crosslinker of claim 7 , wherein in formula (1) X 0 is O.

18. The polydiorganosiloxane vinylic crosslinker of claim 7 , wherein in formula (1) X 0 is NR′ in which R′ is hydrogen or C 1 -C 10 -alkyl.

19. The polydiorganosiloxane vinylic crosslinker of claim 9 , wherein in formula (1) X 0 is O.

20. The polydiorganosiloxane vinylic crosslinker of claim 9 , wherein in formula (1) X 0 is NR′ in which R′ is hydrogen or C 1 -C 10 -alkyl.

21. The polydiorganosiloxane vinylic crosslinker of claim 11 , wherein in formula (1) X 0 is O.

22. The polydiorganosiloxane vinylic crosslinker of claim 11 , wherein in formula (1) X 0 is NR′ in which R′ is hydrogen or C 1 -C 10 -alkyl.

23. The polydiorganosiloxane vinylic crosslinker of claim 2 , wherein the polydiorganosiloxane vinylic crosslinker has a number average molecular weight of from about 4000 Daltons to about 50,000 Dalton.

24. The polydiorganosiloxane vinylic crosslinker of claim 2 , wherein the polydiorganosiloxane vinylic crosslinker has a number average molecular weight of from about 5000 Daltons to about 25,000 Daltons.

25. The polydiorganosiloxane vinylic crosslinker of claim 2 , wherein the polydiorganosiloxane vinylic crosslinker has a number average molecular weight of from about 6000 Daltons to about 18,000 Daltons.

Assignments (3)
CONFIRMATORY DEED OF ASSIGNMENT EFFECTIVE APRIL 8, 2019 Recorded Dec 10, 2019
From: NOVARTIS AG
To: ALCON INC.
Reel/Frame 051454/0788 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 7, 2017
From: HUANG, JINYU; CHANG, FRANK; ZHANG, STEVE YUN; JING, FENG
To: ALCON RESEARCH, LTD.
Reel/Frame 041188/0558 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 7, 2017
From: ALCON RESEARCH, LTD.
To: NOVARTIS AG
Reel/Frame 041188/0599 →
Continuity (2)
Provisional Application 62267310 · Dec 15, 2015
Related Publication 20170166673A1 · Jun 15, 2017
Cited By (20)
US 12,194,698 US 12,194,699 US 12,285,922 US 12,297,323 US 12,351,688 US 12,358,188 US 12,358,247 US 12,360,289 US 12,379,611 US 12,391,014 US 12,392,931 US 12,441,845 US 12,515,423 US 12,539,650 US 12,570,784 US 12,595,368 US 12,638,614 US 12,679,008 US 12,703,161 US 12,715,186